Description

Leptin 22-56 Vials

Leptin -22-56 Peptide
CAS Number	177404-21-6
Molar Mass	2004.3g.mol-1
Chemical Formula	C87H138N22O28S2
IUPAC Name	VPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQK

Introduction

Leptin 22-56 Vials represent an innovative research product tailored exclusively for scientific exploration, devoid of any implication for human consumption. Engineered with precision, these vials contain a specific segment of the leptin peptide, providing researchers with a targeted tool for investigating the multifaceted roles of leptin in various physiological processes.

Key Characteristics

The distinctive feature of Leptin 22-56 Vials lies in the contained peptide sequence, carefully isolated to ensure purity and consistency. Designed with researchers in mind, these vials offer a controlled environment for the study of leptin’s specific molecular actions.

Research Applications

Leptin 22-56 Vials are intended solely for laboratory research purposes, serving as a valuable resource for researchers across diverse scientific disciplines. With a focus on the leptin peptide sequence, these vials provide a platform for in-depth exploration of leptin’s impact on various physiological functions.

Research Benefits

Leptin as an Obese Gene Peptide

Studies have indicated that leptin plays a crucial role as an “obese gene peptide,” influencing metabolic processes and potentially contributing to the regulation of body weight. Leptin 22-56 Vials offer researchers a controlled environment to investigate the molecular mechanisms underlying leptin’s involvement in obesity-related pathways.

Leptin and Bone Growth Factor

Research suggests a connection between leptin and bone growth, implicating leptin as a potential factor in bone metabolism. By utilizing Leptin 22-56 Vials, researchers can explore the peptide’s influence on bone growth factors, paving the way for a deeper understanding of its impact on skeletal health.

Leptin and Hemodialysis Co-Morbidities

Leptin has been implicated in co-morbidities associated with hemodialysis patients. Researchers can leverage Leptin 22-56 Vials to investigate the potential links between leptin and hemodialysis-related complications, offering insights that may contribute to the development of targeted interventions.

Summary

In conclusion, Leptin 22-56 Vials provide a specialized tool for researchers delving into the intricate roles of the leptin peptide. With applications ranging from its involvement in obesity-related pathways to potential impacts on bone growth and hemodialysis co-morbidities, these vials offer a controlled environment for scientific exploration, exclusively for research purposes and not intended for human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1.     Farr OM, Gavrieli A, Mantzoros CS. Leptin applications in 2015: what have we learned about leptin and obesity? Curr Opin Endocrinol Diabetes Obes. 2015 Oct;22(5):353-9. doi: 10.1097/MED.0000000000000184. PMID: 26313897; PMCID: PMC4610373 [Read More]

2. Maor G, Rochwerger M, Segev Y, Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res. 2002 Jun;17(6):1034-43. doi: 10.1359/jbmr.2002.17.6.1034. PMID: 12054158. [Read More]

3. Blüher S, Shah S, Mantzoros CS. Leptin deficiency: clinical implications and opportunities for therapeutic interventions. J Investig Med. 2009 Oct;57(7):784-8. doi: 10.2310/JIM.0b013e3181b9163d. PMID: 19730134; PMCID: PMC5501320. [Read More]